Teleflex to Showcase Minimally Invasive Uterine Surgery Systems at 2nd SEUD Congress

Teleflex to Showcase Minimally Invasive Uterine Surgery Systems at 2nd SEUD Congress

Teleflex, Inc., will showcase its minimally invasive surgery instruments at the 2nd Congress of the Society of Endometriosis and Uterine Disorders (SEUD) taking place in Barcelona, Spain, from May 12 to 14.

Specifically, the company will present the Percuvance, which recently received CE Mark approval for use in Europe, and MiniLap percutaneous surgical systems, and its Weck and Pilling surgical instruments for use in disorders that include endometriosis,  uterine fibroids, polyps, and uterine malformations.

Image Credits: SEUD 2nd Congress
Image Credits: SEUD 2nd Congress

The Percuvance System uses smaller incisions for less invasive surgery than traditional laparoscopic procedures, leaving nearly imperceptible scars, the company said in a press release. Its performance and function, however, is similar to that of other laparoscopic procedures. The system uses a 2.9-mm diameter shaft that can be connected to an introducer tool tip to be inserted directly through a small incision, without an insertion trocar (a medical device for laparoscopic surgeries). According to Teleflex, the shaft is sufficiently strong to hold structures, and surgeons can use its series of 5-mm interchangeable surgical tool tips to manipulate tissue.

A live demonstration of the Percuvance system will be included, in a session called “Hysterectomy with percutaneous instruments.” The surgery will be performed by Dr. Cristiano Rossitto, in Italy, on Thursday, May 12.

MiniLap instruments, according to the company, have a slim, 2.3-mm diameter shaft that can be inserted using an integrated needle tip. The grasper jaws, or probe, are then deployed to grab or coagulate tissue, and can open up to 12.5 mm.

The SEUD Congress, titled “Adenomyosis: new vision for an old challenge,” focuses on the latest research into the treatment and care of adenomyosisendometriosis, and other benign gynecological or uterine ailments.

Leave a Comment

Your email address will not be published. Required fields are marked *